Annual report pursuant to Section 13 and 15(d)

Restatement of Previously Issued Financial Statements (Tables)

v3.22.2.2
Restatement of Previously Issued Financial Statements (Tables)
12 Months Ended
Dec. 31, 2021
Restatement of Previously Issued Financial Statements  
Summary of the effects of the restatement adjustments on each financial statement line item affected by the restatement as of the dates, and for the periods

    

As Previously

Network

Preferred Returns

Class A Units

Revenue

    

Reported

    

Adjustments

    

Adjustments

    

Adjustments

    

Adjustments

    

As Restated

Consolidated Balance Sheet as of December 31, 2020

Health Plan Settlement Receivable

$

38,429,833

$

$

$

$

6,532,954

$

44,962,787

Total Current Assets

84,347,633

6,532,954

90,880,587

Total Assets

99,902,252

6,532,954

106,435,206

Class A Units Subject to Possible Redemption

43,656,270

43,656,270

Class D Units Subject to Possible Redemption

51,608,900

(4,567,346)

47,041,554

Contributed Capital

41,764,270

(41,764,270)

Class A Preferred Returns

3,815,034

(3,815,034)

Accumulated Equity-Based Compensation

1,368,567

(921,092)

447,475

Retained Loss from Non-Controlling Interests

 

(18,187,381)

 

18,187,381

 

Accumulated Deficit (formerly Accumulated Loss from Controlling Interest)

(126,242,225)

(18,187,381)

8,382,381

(970,908)

6,532,954

(130,485,179)

Total Member’s Deficit

(97,661,735)

4,567,346

(43,656,270)

6,532,954

(130,217,705)

Total Liabilities, Mezzanine Equity & Members' Equity (Deficit)

99,902,252

6,532,954

106,435,206

Consolidated Statement of Operations for the Year Ended December 31, 2020

 

  

 

Capitated Revenue

$

471,551,241

$

$

$

$

9,188,336

$

480,739,577

Other Patient Service Revenue

13,990,050

(3,666,102)

10,323,948

Total Operating Revenue

485,541,291

5,522,234

491,063,525

Medical Expenses

485,513,143

(1,010,720)

484,502,423

Total Operating Expenses

520,661,923

(1,010,720)

519,651,203

Operating Loss

(35,120,632)

6,532,954

(28,587,678)

Interest Expense, net

(9,970,260)

7,437,080

(2,533,180)

Total Other Income (Expense)

(10,260,944)

7,437,080

(2,823,864)

Net Loss Attributable to Non-Controlling Interests

(4,307,071)

4,307,071

Net Loss (formerly Net Loss Attributable to Controlling Interests)

 

(41,074,505)

 

(4,307,071)

7,437,080

6,532,954

 

(31,411,542)

Consolidated Statements of Changes in Members' Deficit for the Year Ended December 31, 2020

Preferred Return(s) at 8% (Class A + Class D Units)

$

7,437,080

$

$

(7,437,080)

$

$

$

Net Loss

(45,381,576)

7,437,080

6,532,954

(31,411,542)

Balance as of December 31, 2020

(97,661,735)

4,567,346

(43,656,270)

6,532,954

(130,217,705)

Consolidated Statements of Cash Flows for the Year Ended December 31 2020

Net Loss

$

(45,381,576)

$

$

7,437,080

$

$

6,532,954

$

(31,411,542)

Health Plan Settlements Receivable/Premiums Receivable

(20,974,286)

(6,532,954)

(27,507,240)

Class A and Class D Preferred Returns

7,437,080

(7,437,080)

Consolidated Balance Sheet as of December 31, 2019

 

  

 

 

Class A Units Subject to Possible Redemption

$

$

$

$

43,656,270

$

$

43,656,270

Class D Units Subject to Possible Redemption

47,556,622

(515,068)

47,041,554

Contributed Capital

41,764,270

(41,764,270)

Class A Preferred Returns

430,230

(430,230)

Accumulated Equity-Based Compensation

921,092

(921,092)

Retained Loss from Non-Controlling Interests

 

(13,880,310)

 

13,880,310

 

Accumulated Deficit (formerly Accumulated Loss from Controlling Interest)

(85,167,716)

(13,880,310)

945,297

(970,908)

(99,073,637)

Total Member’s Deficit

(55,932,434)

515,068

(43,656,271)

(99,073,637)

Consolidated Statement of Operations for the Year Ended December 31, 2019

 

  

 

 

Capitated Revenue

$

138,727,943

$

$

$

$

604,764

$

139,332,707

Other Patient Service Revenue

7,166,889

(1,017,484)

6,149,405

Total Operating Revenue

145,894,832

(412,720)

145,482,112

Medical Expenses

141,442,457

(412,720)

141,029,737

Total Operating Expenses

185,430,503

(412,720)

185,017,783

Interest Expense, net

(3,479,139)

945,297

$

(2,533,842)

Total Other Income (Expense)

(3,381,184)

945,297

(2,435,887)

Net Loss Attributable to Non-Controlling Interests

(7,907,592)

7,907,592

Net Loss (formerly Net Loss Attributable to Controlling Interests)

 

(35,009,263)

 

(7,907,592)

945,297

 

(41,971,558)

Consolidated Statements of Changes in Members' Deficit for the Year Ended December 31, 2019

Preferred Return(s) at 8% (Class A + Class D Units)

$

945,298

$

$

(945,298)

$

$

$

Net Loss

(42,916,855)

945,297

(41,971,558)

Conversion of Debt to Class A Units

3,764,025

(3,764,025)

Class A Units Issued

11,184,468

(11,184,468)

Redemption of Class A Units

(15,000,000)

15,000,000

Modification of Class A

(1,892,002)

(1,892,002)

Balance as of December 31, 2019

(55,932,434)

515,068

(43,656,271)

(99,073,637)

Consolidated Statements of Cash Flows for the Year Ended December 31 2019

Net Loss

$

(42,916,855)

$

$

945,297

$

$

$

(41,971,558)

Class A and Class D Preferred Returns

945,297

(945,297)

Consolidated Statements of Changes in Members' Deficit for the Year Ended December 31, 2018

Balance as of December 31, 2018

$

(13,868,589)

$

$

$

(41,815,530)

$

$

(55,684,119)